Stay updated on CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, indicating a new version of the page has been deployed.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page revision is updated from v3.6.0 to v3.6.2, indicating a software release; it does not alter the study data or user-facing content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedRecruitment is now listed as 'No longer looking for participants', indicating that enrollment is closed. The page adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading, with the revision version updated to v3.6.0.SummaryDifference0.4%

- Check31 days agoChange DetectedThe page now displays a new revision tag v3.5.5 replacing v3.5.4, indicating a minor update to the page content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision label was updated from Revision: v3.5.3 to Revision: v3.5.4, signaling a new build of the site. This change represents an underlying software update rather than a modification to the Study Details content.SummaryDifference0.1%

- Check73 days agoChange DetectedThe Publications section has been updated to reflect the final journal citation details for the “CALYPSO: Final Results…” paper (replacing the earlier online-ahead-of-print version). The page’s revision/version label also changed from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CALYPSO: MEDI4736 Combos in Renal Cell Carcinoma Clinical Trial page.